SAN DIEGO, Aug. 30 /PRNewswire/ — Millennium
Laboratories, a leading provider of therapeutic drug monitoring
and education to physicians and staff treating chronic pain,
announced today the appointment of David Cohen to Chief Operating
Officer. In his capacity as COO, Mr. Cohen is responsible for new
business analysis and development to expand the Company’s core
business. He also has oversight of Millennium’s legislative
initiatives and community outreach programs.
(Photo: http://photos.prnewswire.com/prnh/20100830/LA56535)
(Photo: http://www.newscom.com/cgi-bin/prnh/20100830/LA56535)
“David’s track record of success in negotiation fund raising,
SEC compliance and investor relations brings tremendous value to
Millennium,” said James
Slattery, Chief Executive Officer. “His experience has already
contributed greatly to our expansive growth and enhanced our
reputation in the pain management arena.”
“It’s an honor to take on this new challenge at Millennium and
to build on the momentum created by our new marketing, sales and
operational initiatives,” stated Cohen. “Our customer focus and
emphasis on groundbreaking research position us to take Millennium
to the next level.”
David Cohen originally joined Millennium Laboratories as Chief
Analytics Officer. In his 28-year career, Mr. Cohen has served as a
public company Chief Financial Officer, Controller and later
Executive Vice president of a $500 million dollar real estate
conglomerate operating in 38 states and the commonwealth of Guam.
He has also been involved with several start-ups and turnaround
situations. His reputation as a skilled negotiator is well-earned
– he has raised more than $35 million for specific projects
in private
‘/>”/>
SOURCE